IRAK4-IN-31

IRAK4-IN-31 (Compound II) is a crystalline IRAK4 inhibitor. IRAK4-IN-31 can be used in myelodysplastic syndrome (MDS) research[1].

Product Specifications

CAS Number

[2967595-44-2]

UNSPSC

12352005

Target

IRAK

Related Pathways

Immunology/Inflammation

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Smiles

COC1=CC2=NN(C=C2C=C1C(NC3=CC=CN(C3=O)C4CC4)=O)[C@@H]5CC[C@H](CC5)N(C([C@@H](O)C)=O)C

Molecular Formula

C27H33N5O5

Molecular Weight

507.58

References & Citations

[1]Christopher Sebastian Gerald KNEE, et al. Crystalline irak4 inhibitors. WO2016028092A2. Astrazeneca Ab. 2024-08-09.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

IRAK4

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-98009UV 0.1 mL

Rabbit Polyclonal SCAP2 Antibody [DyLight 350]

Ask

View Details

MBS7154821 Inquire

Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c)(Baker's yeast) URA10 Polyclonal Antibody

Ask

View Details

SC204733 10 µg

SNF5 (SMARCB1) (NM_001007468) Human 3' UTR Clone

Ask

View Details

JBS-NU-824-CY3 160 μL

EDA-m7GTP – Cy3

Ask

View Details

GTR15284989 1 Vial

Lentiviral mouse Hspa12b shRNA (UAS) - Lentiviral mouse Hspa12b shRNA (UAS, RFP) plasmid

Ask

View Details

MBS1368100-01 0.02 mg (E-Coli)

Recombinant Staphylococcus haemolyticus Acetate kinase (ackA)

Ask

View Details